Amagra SA
Amagra reported total assets of €1.95m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Amagra shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amagra's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 05 Jul 2024
- Year ended 31 Dec 2022filed on 08 Aug 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Amagra's financial analysis
- Solvency60.9%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amagra
Amagra's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.431.763
- VAT number
- BE0451431763
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 22 Nov 1993
- Registered office
- 7911 Frasnes-lez-Anvaing
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Amagra (SA) has been based in Frasnes-lez-Anvaing since 1993, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 53,715 € and equity of €1.19m; its revenue is not published. Its solvency stands at 60.9%, above the median of its sector (38.7%).
Companies similar to Amagra
Companies in the same business, of comparable size and area, outside its group.
- MVV Immo Buying and selling of own real estate Ath · balance sheet €1.95m
- DI Nero Dilsen-Stokkem · balance sheet €1.95m
- Dokter Philippe Jamaer Medical specialists activities Herk-de-Stad · balance sheet €1.95m
- Pinewood Estate Buying and selling of own real estate Mechelen · balance sheet €1.95m
- D & H Rental and operating of own or leased real estate Antwerp · balance sheet €1.94m
Frequently asked questions about Amagra
What is the revenue of Amagra?
Amagra files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amagra?
In Belgium, the VAT number is the company number prefixed with BE: BE0451431763 for Amagra, if the company is VAT-registered. Its company number (CBE) is 0451.431.763.
Where is the registered office of Amagra?
According to the CBE register, the registered office of Amagra is in 7911 Frasnes-lez-Anvaing.
What is the equity of Amagra?
At the close of the 2025 financial year, the equity of Amagra amounts to 1,185,595 €, a solvency of 60.9% of total assets.
Who manages Amagra?
The register lists 6 active mandates at Amagra. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amagra
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →